DBI-2
Product Specifications
UNSPSC Description
DBI-2 is an AMPK activator targeting mitochondrial complex I. DBI-2 disrupts the OXPHOS process, and reduces ATP generation in mitochondria. DBI-2 inhibits the proliferation of colorectal cancer (CRC) cells[1].
Target Antigen
AMPK; Mitochondrial Metabolism
Type
Reference compound
Related Pathways
Epigenetics;Metabolic Enzyme/Protease;PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dbi-2.html
Smiles
CN(CCN(C)CCCCOC1=CC=C2C(OC=C(C3=CC=C(Br)C=C3)C2=O)=C1)C
Molecular Weight
473.40
References & Citations
[1]Lichao Guo, et al. Inhibition of Carbohydrate Metabolism Potentiated by the Therapeutic Effects of Oxidative Phosphorylation Inhibitors in Colon Cancer Cells. Cancers (Basel). 2024 Apr 2;16(7):1399.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162516/DBI-2-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162516/
Clinical Information
No Development Reported
CAS Number
2939087-00-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
